Drug intelligence / Profile preview

Y-90 glass microspheres

Development stage
Unknown
Lead developer
Boston Scientific
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Beta-minus Emitters → Radiopharmaceuticals
Administration
Intra-arterial
01

Overview

Y-90 glass microspheres are microscopic beads made of insoluble glass containing radioactive yttrium-90, a pure beta emitter. They are delivered via microcatheter into the hepatic artery, targeting liver tumors with localized, high-dose radiation while sparing much of the surrounding hepatic parenchyma. Upon administration, the microspheres become permanently lodged in tumor vasculature, emitting beta radiation that damages tumor DNA and induces cell death. The radiation decays rapidly, with most delivered within two weeks, while the stable glass beads remain embedded indefinitely. Y-90 glass microspheres are primarily used as selective internal radiation therapy (SIRT) for unresectable hepatocellular carcinoma (HCC) and have demonstrated efficacy in primary and metastatic liver tumors, including liver metastases from colorectal cancer.

Brand names
TheraSphere
Other names
Yttrium-90 glass microspheresYttrium90 glass microspheresYttrium 90 glass microspheres
02

Targets

DNA

Beyond the preview

Go deeper on Y-90 glass microspheres.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Y-90 glass microspheres.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call